With the hopes of broadening access to COVID-19 care, the FDA allowed pharmacists to prescribe Pfizer’s antiviral treatment Paxlovid on July 6.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News